Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $113.5746 (3.22%) ($110.3186 - $114.1492) on Sun. Feb. 18, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.4% (three month average) | RSI | 44 | Latest Price | $113.5746(3.22%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 1.3% a day on average for past five trading days. | Weekly Trend | ABBV declines -0.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting ABBV price | ABBV will decline at least -1.2% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.2% (StdDev 2.4%) | Hourly BBV | 0 () | Intraday Trend | 2.9% | | | |
|
5 Day Moving Average | $109.24(3.97%) | 10 Day Moving Average | $107.81(5.35%) | 20 Day Moving Average | $108.06(5.1%) | To recent high | -3.7% | To recent low | 27.6% | Market Cap | $N/A | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |